Sage Journals: Discover world-class research

Abstract

OBJECTIVES: To investigate the role of the inflammatory cytokine interleukin-1β (IL-1β) in the regulation of mucin secretion by middle ear epithelia.

STUDY DESIGN AND SETTING: Primary chinchilla middle ear epithelial cultures were established and exposed to IL-1β in a dose- and time-dependent manner. Mucin secretion was characterized by exclusion chromatography and liquid scintillation.

RESULTS: Epithelial cultures exposed to increasing doses of IL-1β demonstrated greater amounts of mucin secretion (P = 0.007). Additionally, cultures exposed to IL-1β at 50 ng/mL showed increased secretion of mucin over control noticeable at 6 hours, but significant at the 15- and 24-hour time points (P > .0001 for each).

CONCLUSIONS: IL-1β upregulates mucin secretion from cultured middle ear epithelial cells in a dose-and time-dependent manner.

SIGNIFICANCE: Elucidating the effect of specific cytokines on the regulation of mucin secretion is vital to understanding the pathophysiology of otitis media and the development of novel therapeutic strategies.

Get full access to this article

View all access options for this article.

References

Bluestone

Otitis media, atelectasis, and eustachian tube dysfunction. Vol. 1. Philadelphia (PA): WB Saunders; 1996.

Rosenfeld

Casselbrant

Hannley

Implications of the AHRQ evidence report on acute otitis media. Otolaryngol Head Neck Surg 2001; 125:440–8.

Chonmaitree

Patel

Sim

Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol 1996; 105:968–74.

Juhn

Garvis

Lees

Determining otitis media severity from middle ear fluid analysis. Ann Otol Rhinol Laryngol Suppl 1994; 163:43–5.

Maxwell

Fitzgerald

Burleson

Interleukin-8 expression in otitis media.

Laryngoscope 1994; 104(8 Pt 1):989–95.

Yellon

Doyle

Whiteside

Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg 1995; 121:865–9.

Kerschner

Beste

Lynch

Interleukin-1 receptor antagonist as an adjunct in the treatment of Haemophilus influenzae otitis media in the chinchilla. Laryngoscope 2000; 110:1457–61.

Nolan

Turner

Expression of tracheal differentiated functions in serum-free hormone-supplemented medium. J Cell Physiol 1985; 125:167–81.

Adler

Cheng

Kim

Characterization of guinea pig tracheal epithelial cells maintained in biphasic organotypic culture: cellular composition and biochemical analysis of released glycoconjugates. Am J Respir Cell Mol Biol 1990; 2:145–54.

10.

Lin

Kim

Lees

Effect of platelet-activating factor on secretion of mucous glycoprotein from chinchilla middle ear epithelial cells in vitro. Eur Arch Otorhinolaryngol 1995; 252:92–6.

11.

Brown

Litt

Potsic

A study of mucus glycoproteins in secretory otitis media. Arch Otolaryngol 1985; 111:688–95.

12.

Carrie

Hutton

Birchall

Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol 1992; 112:504–11.

13.

FitzGerald

Green

Stafford

Characterization of human middle ear mucus glycoprotein in chronic secretory otitis media (CSOM). Clin Chim Acta 1987; 169:281–97.

14.

Hutton

Fogg

Murty

Preliminary characterization of mucin from effusions of cleft palate patients. Otolaryngol Head Neck Surg 1993; 109:1000–6.

15.

Fischer

Krunkosky

Wright

Tumor necrosis factor-alpha (TNF-alpha) stimulates mucin secretion and gene expression in airway epithelium in vitro.

Chest 1995; 107(3 Suppl):133S–135S.

16.

Larivee

Levine

Martinez

Platelet-activating factor induces airway mucin release via activation of protein kinase C: evidence for translocation of protein kinase C to membranes. Am J Respir Cell Mol Biol 1994; 11:199–205.

17.

Levine

Larivee

Logun

Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 1995; 12:196–204.

18.

Fong

Moldawer

Shires

The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990; 170:363–78.

19.

Dinarello

Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44:153–205.

20.

Platanias

Vogelzang

Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med 1990; 89:621–9.

21.

Himi

Suzuki

Kodama

Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1992; 157:21–5.

22.

Yellon

Leonard

Marucha

Characterization of cytokines present in middle ear effusions. Laryngoscope 1991; 101:165–9.

23.

Dinarello

Thompson

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12:404–10.

24.

Norman

Franz

Messina

Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995; 117:648–55.

25.

Arend

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991; 88:1445–51.

26.

Dinarello

Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77:1627–52.

Middle ear epithelial mucin production in response to interleukin 1β exposure in vitro

Abstract

Get full access to this article

References